Search hospitals > Missouri > Saint Louis
Saint Louis Cancer and Breast Institute-South City
Claim this profileSaint Louis, Missouri 63109
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Stomach Cancer
260 reported clinical trials
1 medical researcher
Summary
Saint Louis Cancer and Breast Institute-South City is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Saint Louis Cancer and Breast Institute-South City is involved with conducting 260 clinical trials across 426 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Clinical Trials running at Saint Louis Cancer and Breast Institute-South City
Breast Cancer
Bladder Cancer
Lung Cancer
Thyroid Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Bladder Carcinoma
Stomach Cancer
Ovarian Cancer
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Louis Cancer and Breast Institute-South City?
Saint Louis Cancer and Breast Institute-South City is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Breast cancer, Stomach Cancer and other specialties. Saint Louis Cancer and Breast Institute-South City is involved with conducting 260 clinical trials across 426 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.